Based on the earnings conference call transcripts, the financial metrics for the company are as follows:

Sales: Sales in the March quarter increased for the sixth consecutive quarter to $609 million, up 4% sequentially and up 7% on a year-over-year basis.

Gross Margin: Gross margin was 69.5%, at the high end of the guidance, due primarily to favorable end market mix.

Operating Expense: Operating expense was $250 million, $6 million higher than guided due to accelerated 16-nanometer tape-out expenses and increased litigation expense.

Operating Income: Operating income for the quarter increased 6% sequentially to $173 million or 28.5%.

Net Income: Net income for Q4 was $153 million or $0.57 per share.

Cash Flow: Operating cash flow was $306 million for the quarter, leading to a record $934 million in operating cash flow for the year.

Return to Shareholders: The company returned $855 million to shareholders through dividends and share repurchases.

Balance Sheet: The company ended the quarter with $3.4 billion in gross cash and $2 billion in net cash after debt. Accounts receivables decreased, while inventory increased, primarily from Advanced Products.

Guidance: For the June quarter, the company is expecting sales to be between $600 million and $630 million, with gross margin approximately 68% to 70%. Operating expense is expected to decline to approximately $242 million, with a tax rate between 12% and 15%. Full year FY 2018 guidance will be provided at the upcoming Analyst Meeting in May.

Overall, the company has shown growth in sales and profitability, strong cash flow, and a focus on capital allocation and returning value to shareholders. The company also provided guidance for the upcoming quarter, expecting continued growth in Advanced Products and specific end market trends.